Curriculum Vitae - Vijaya College of Pharmacy
-
Upload
khangminh22 -
Category
Documents
-
view
1 -
download
0
Transcript of Curriculum Vitae - Vijaya College of Pharmacy
1
Curriculum Vitae
Dr. R.SUTHAKARAN M.Pharm., Ph.D., DPMM., DPQCQAM, DCA.
F.No.505, Ajitha Towers,
Road No.4/1 Haripuri Colony,
R.K.Puram, Kothapet, Hyderabad-500035.
Andhra Pradesh, India
Mobile: 91-9440394053, 91-9704511195
E-mail: [email protected]
ACADEMIC CHRONICLES
Year Degree Institution / University Class
2005 - 2010 PhD SASTRA University,
ADDITIONAL QUALIFICATIONS
Year Degree Institution / University
1997 D.P.Q.C.Q.A.M.
1996-1997 D.P.M.M.
Institute of Pharmaceutical Education Research
(IPER), Pune, Maharastra, India.
Institute of Pharmaceutical Education Research
(IPER), Pune, Maharastra, India.
PhD Thesis Title:
“Synthesis and Pharmacological Investigations of Some New 4(3H)-Quinazolinone
analogs and QSAR, CADD studies”
(Pharmaceutical Chemistry) Tanjavur, Tamil Nadu, India.
1998 - 2000
M.Pharm.
(Pharmaceutical Chemistry)
K.M,College of Pharmacy, Madurai,
MGR Medical University,
I
Chennai,Tamil Nadu, India
1993 - 1997
B.Pharm.
A.K. College of Pharmacy, Madurai,
MGR Medical University,
I
Chennai,Tamil Nadu, India
2
WORKING EXPERIENCES
07-12-2015 to till date Working as Principal and Professor. Vijaya College of
Pharmacy, Hyderabad, Andhra Pradesh, India.
05-07-2013 to 05-12-2015 . Principal and Professor, Teegala Ram Reddy College of
Pharmacy, Hyderabad, Andhra Pradesh, India.
03-07-2013 to 04-07-2013 Worked as Principal and Professor, Vijaya College of Pharmacy,
Hyderabad, Andhra Pradesh, India.
9-10-2010 to 02-07-2013 Principal and Professor, Teegala Ram Reddy College of
Pharmacy, Hyderabad, Andhra Pradesh, India.
2008-2010
14-7-2009 to 8-10-2010
Principalv& Professor Smt. Sarojini Ramulamma College of
Pharmacy, Mahabubnagar, Andhra Pradesh, India.
2007-2008
4-7-2007 to 4-7-2009
Principal (In-charge) & Asso.Professor Vijaya College of
Pharmacy, Hyderabad, Andhra Pradesh, India.
2005 – 2007
15-6-2005 to 1-7--2007
Assistant Professor in S.N. Vanitha Pharmacy Mahavidyalaya,
Hyderabad, Andhra Pradesh, India.
2001 -2005
12-10-2001 to 13-6-2005
Assistant Professor in Smt. Sarojini Ramulamma College of
Pharmacy, Mahabubnagar, Andhra Pradesh, India.
2000-2001
3-1-2000 to 3-10-2001
Assistant Professor in Fathima College of Pharmacy,
Kadayanallur, Tamil Nadu, India.
1997-1998
13-08-1997 to 13-08-1998 Lecturer in N.M.S. College of Pharmacy, Tamil Nadu, India.
3
WORKING EXPERIENCES
3)07-12-2015 to till date
2) 03-07-2013 to 04-07-
Working as Principal and Professor. Vijaya College of
2013 Pharmacy, Hyderabad, Andhra Pradesh, India.
1) 4-7-2007 to 4-7-
2009
2) 05-07-2013 to 05-
Principal and Professor, Teegala Ram Reddy College of
Pharmacy, Hyderabad, Andhra Pradesh, India.
12-2015
1) 9-10-2010 to 02-
07-2013
2) 14-7-2009 to 8-10-
2010 Principal & Professor Smt. Sarojini Ramulamma College of
1) 12-10-2001 to 13-
Pharmacy, Mahabubnagar, Andhra Pradesh, India.
6-2005
15-6-2005 to 1-7--2007 Assistant Professor in S.N. Vanitha Pharmacy Mahavidyalaya,
Hyderabad, Andhra Pradesh, India.
3-1-2000 to 3-10-2001 Assistant Professor in Fathima College of Pharmacy,
Kadayanallur, Tamil Nadu, India.
13-08-1997 to 13-08-1998 Lecturer in N.M.S. College of Pharmacy, Tamil Nadu, India.
ACREDITATIONS
*Recognized and Ratified as Professor, Asst.Professor by the Staff Selection Committee
of Osmania University, Hyderabad, Andra Pradesh, India.
*Recognized and Ratified as Asso. Professor by the Staff Selection Committee of J.N.T,
University, Hyderabad, Andra Pradesh, India.
*PhD Evaluator in Karpakam University
4
1) Convener- Two day national level DST- SEMINAR GRAND 50000 SERB?F/7993/2015
Dt,16/02/2016 on Industrial chemistry and Green chemistry
2) *DST- NRDMS project worth 1000000 as a Principal Investigator
Project Title
Risk Analysis of Encephalitis Disease in Khammam District (Telangana State) and Geospatial
Approach for Surveillance
File No: - NRDMS/01/176/2016
Natural Resources Data Management System
3) Co-convener – One day national level DST- SEMINAR GRAND 50000 –Impact of
biopharmaceutical engineering and its applications on human health on 16/03/2018
Testimonials /Seminars/Conferences/Symposium/Journal Referee/Thesis evaluator/Guide
S.No Particulars No.
1. Seminars and presented papers 200
2 Conferences 35
3 Workshops 07
4 Quality improvement programme (QIP) 02
5 Journal referee 02
6 Examiners 07 Universities
7 Question paper setting 02 Universities
8 B.Pharm thesis evaluator 05 universities
9 M.Pharm thesis evaluator 05 universities
10 PhD thesis evaluator 02 universities
11 B.Pharm guide 02 groups
12 M.Pharm guide 40 members
13 PhD guide 04 members in 04 universities
14 Membership 02 Life member
15 Industrial trips 04
16 Grant to AICTE Applied
17 Grant to ICMR Applied
5
18 Grant to DST 4) SEMINAR GRAND
50000
SERB?F/7993/2015
Dt,16/02/2016
2)DST- NRDMS project
worth 1000000 as a
Principal Investigator
Project Title Risk
Analysisof
Encephalitis Disease in
Khammam District
(TelanganaState)and
Geospatial Approach for
Surveillance
File No: -
NRDMS/01/176/2016
Natural Resources Data
Management System
19 Industrial collaborations 02
20 Foreign university collaborations Applied
21 IPC-2018 Elocution competition Judge
23/11/2018 at Sri indu Institute of pharmacy-
Hyderabad
RESEARCH PUBLICATIONS
National 120
International
Presentations 200
List of articles in – PAPER
PUBLICATIONS
6
1. R.Suthakaran, Gopinath, SSrikanth, S.B. Muthu et al. Analytical profile of raw material
and finished product of cefuroxime axetil. Int J of Research and development in
pharmacy and life sciences. 2013; 2(2):371-376. ISSN: 2278-0238.
2. Sudha parimala, V. Hemanthkumar, S.M Shantha kumar, R.Suthakaran, A. Tamil selvan.
Analgesic and CNS depressant activity of methanoic extract of Cissus vitegenia and
Cissus pallida. Int J of research and development in pharmacy and life sciences. 2013;
2(2):330-332. ISSN: 2278-0238
3. R.Suthakaran. Legal protection of intellectual property rights. Int. J of pharmacy.
2013;3(4):835-836. ISSN: 2249-1848.
4. Naga malleswra rao, K.Venkata kumar,C. Madhuri kommoju , R.suthakaran et al.
Tandem mass spectrometric method for the quantitative determination of pioglitazone
and their metabolites in human plasma by using liquid-liquid extraction technique and its
application to pharmacokinetic studies. American J of Pharmtech research.
2013;3(4):314-330. ISSN: 2249-3387.
5. KVM Krishna, Raju manda, R.suthakaran. Formulation and evaluation of antidiabetic
herbal extract preparation. JPR online.BIOMED RX 2013;1(5): 555-557.
6. R,Suthakaran. Regulatory requirements for generic drug product in Japan. World journal
of pharmacy and pharmaceutical sciences. 2013; 2(5):XXX. ISSN: 2278-4357.
7. R,Suthakaran, srikanth, kshemada kappagantu, A,tamil selvan, S.B muthu vadivel.
Synthesis and invitro evaluation of novel urea derivatives as ACE inhibitors. JPR online.
2013;1(1): 24-31.
8. R,Suthakaran. Regulatory process involved in generic drug approval process in USA,
Europe and India. Indo American J of Pharm Res. 2013; 3(12):1451-1456.ISSN: 2231-
6876.
9. R.Suthakaran. comparative study of regularory requirements for the approval of generic
drugs for association of south east asian nation (ASEAN), Gulf co-operative council
(GCC) and united states food and drug administration (USFDA). JPR online. 2014;8(1):
59-63.
10. R.Suthakaran. the assessment of current regulatory guidelines for biosimilar- A flobal
scenario. JPR online. 2014;8(1):49-52.
11. R Suthakaran, K.Rajesh, K.sunil kumar, P.manasa. Comparative profiles of
neuromuscular blocking properties of leaves and seeds of plant vicia faba. Int J of
Innovative pharmaceutical sciences and research. 2014;2(1):535-541.ISSN: 2347-2154.
12. D.V.R.N. Bikshapathi, V.Durga madhuri, V.V. Rajesham, R.suthakaran. preparation and
evaluation of Fast dissolving oral film containing naratriptan Hcl. American J of pharm
tech research. 2014;4(2): 799-812. ISSN: 2249-3387.
13. K.sunil kumar, R.suthakaran, K.rajesh, B.K.Jayalakshmi. gastroprotective activity of
celosia argentea leaves against stress induced ulcers in rats. World J of Pharm Res. 2014;
3(2):2709-2715. ISSN: 2277-7105.
7
14. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S. concept of 505(b)(2)
Applicationn: Benefits and challenges. Int J of Drug regulatory affairs. 2014;2(2):16-20.
ISSN: 2321-6794.
15. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S, naveen reddy M. exclusivity
strategies of innovator drug developers. Int J of drug regulatory affairs. 2014;2(2):21-25.
ISSN: 2321-6794.
16. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S, Abhijit K. Indonesian patent
system: An overview. Int J of Drug regulatory affairs. 2014;2(2):26-30. ISSN: 2321-
6794.
17. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S. An overview of Iranian patent
system. Asian J of pharm tech and Innovation. 2014;2(6):1-7. ISSN: 2347-8810.
18. Chaitanya Prasad Kolla*1, Prabodh M1, Rastrapal D1, Suthakaran R1 , The Purview of
Regulatory Affairs in the Pharmaceutical Industry, Asian Journal of Pharmaceutical
Technology & Innovation, 02 (06); 2014; 01-06, ISSN: 2347-8810
19. Nadipineni AK. Dileep KG, Ravindra CK, Suthakaran R. An overview of Chinese drug
regulatory system: A review. Int J Of drug regulatory affairs. 2014; 2(3):14-18. ISSN:
2321-6794.
20. Raju.M, Virajaj kaya, B.Sreedevi, R,sai santhosh, R.suthakaran. design and invitro
evaluation of non erodible polymeric matrix tablets of Isoniazid using sintering
technique. World J of Pharm.Res. 2014;3(7):507-515. ISSN: 2277-7105.
21. Raju.M, Virajaj kaya, B.Sreedevi, R. Navya, R.suthakaran. Design, fabrication and
evaluation of drug release kinetics from Metformin HCl sustained release matrix tablets
by using natural gums. World J of Pharm.Res. 2014; 3(7):499-506. ISSN: 2277-7105.
22. Raju.M, Virajaj kaya, B.Sreedevi, B.Kusuma Pravallika, R.suthakaran. Non-ionic
surfactant based vesicle Niosome as a potential ocular drug delivery system. World J of
Pharm.Res. 2014;3(11):XXX. ISSN: 2278-4357.
23. Raju.M, Virajaj kaya, B.Sreedevi, T.H. Fathima, R.suthakaran. Niosome: An unique drug
delivery system. World J of Pharm.Res. 2014;3(11):XXX. ISSN: 2278-4357.
24. Chaitanya Prasad, R,suthakaran. New drug development and various drug applications
under FDA. Emerging trends in drug discovery. AICADD-2014.
25. K.sunil kumar, K,rajesh, D.anusha, r.suthakaran. potentiation of phenobarbitone induced
hypnosis by celosia argentea leaves. Int J of medicine and Pharm.Res. 2014;2(3):591-
594. ISSN: 2321-2624.
26. P.deepika, R.suthakaran. validated RP-HPLC method as a tool for the estimation of
tinidazole in pharmaceutical dosage forms. Int J of research and development in
pharmacy and life sciences. 2014;3(4):1089-1092. ISSN: 2278-0238.
27. Chaitanya Prasad, prabodh M, Rastrapal D, Suthakaran R. The purview of regualatory
affairs in the pharmaceutival industry. Asian J of pharm tech and Innovation.
2014;2(6):1-6. ISSN: 2347-8810.
8
28. Chaitanya Prasad, Prabodh M, Rastrapal D, Suthakaran R.prescription drug user fee act
and its influence on review time and budget. J of pharamacreations. 2014;1(2):41-46.
29. P.raghavendra, G.veena, N.sangeetha, Srivennela, R.Suthakaran. Microwave synthesis
and anti-inflammatory evaluation of some new imidazolo quinoline analaogs.
2011;4(1):91-102. ISSN: 0974-1496.
30. P.Raghavendra, G.veena, Srivennela, R.Suthakaran et al. synthesis, antioxidant and
antimicrobial study of novel imidazolo-quinoline derivatives. International journal of
chemical and analytical sciences, 2011;2(6):62-69. ISSN: 0976-1206.
31. C.H.Sridevi,K.Balaji, A.Naidu R.Suthakaran. synthesis of some phenyl
pyrazolobenzimidazoloquinoxaline derivatives as potent antihistaminic agents. E-J
Chem.2010;7(1):234-238.
32. Shashank D, Vishwanath T, Balasubramaniam V, Suthakaran R. synthesis of some
substituted benzothiazole derivatives and its biological activities. Int J of Pharmtech
Res.2009; 1(4):1224. ISSN: 0974-4304.
33. G.Tuljarani, D.Gowrishankar, P.Kadgapathi, R,Suthakaran. Viswible spectrophotometric
determination of Rosuvastatin in bulk and pharmaceutical formulations. Oriental J of
chemistry. 2010; 6(2):589-593. ISSN: 2231-5039.
34. R.Suthakaran A.Tamil selvan, Ravali and S.Prithvi. Effect of Piper methysticum root on
CNS activity. Journal of Pharmacy and Phytotherapeutics. 2013;1(4): 1-4. ISSN:
35. R.Suthakaran A.Tamil selvan, R.P.Ashwini, B.Jayalaxmi and M.Viswanath.
Bioevaluation of Sirupeelai samoolam herbal formulation for Antiurolithiatic activity.,
International Journal of Research in Pharmacology & Pharmacotherapeutics. 2013;2(2):
1-6. ISSN: 2278-2656.
36. A.Tamilselvan, R.Suthakaran et al. Phytochemical and Pharmacological validation of the
polyherbal extract on rodents. International Journal of Medical Sciences and
Biotechnology. 2013; 1(2): 23-29.
37. Phytochemical, Pharmacognostical and Pharmacological evaluation of polyherbal
extract, I(II), sept2013, 33-40. International Journal of Medical Sciences and
Biotechnology.
38. A.Tamilselvan, R.Suthakaran et al. Phytochemical evaluation and Anti inflammatory
activity of Boswellia ovalifoliolata. International Journal of Pharmaceutical Sciences
Review and Research.2013; 22(1): 148-151.
39. R.Suthakaran A.Tamil selvan, S.Ramya sree, S.R.Navya sree, Mohammed ehtesham
uddin, KVM Krishna, , Application of immunosuppressant cyclophosphamide in the
9
treatment of systemic lupus erythematosus , world journal of pharmacy and
pharmaceutical sciences,2013 volume 2, issue 4, 1695-1698. ISSN: 2278-4357.
40. R.Suthakaran A. Tamil Selvan, Gutha Girisha, Vijaybhaskar, , Comparative evaluation of
newer topical antifungal agents in the treatment of superficial fungal infections (Tinea or
Dermatophytic), Int. Res. J. Pharm. 2013, 4 (X).
41. Suthakaran R, KVM Krishna, Raju Manda ,Formulation and Evaluation of Anti diabetic
Herbal Extract Preparation, BioMedRx 2013,1(5),555-557 .
42. R. Suthakaran Sudha Parimala, V.Hemanth Kumar, S.M.Shanta Kumar, A.Tamil Selvan,
In vitro anti diabetic and anti oxidant activity of methanolic extracts of Cissus pallida and
Cissus vitegenia, BioMedRx 2013, 1(4), 374-376.
43. Suthakaran, Sudha Parimala, V. Hemanth Kumar, S. M. Shanta Kumar, A. Tamil Selvan,
In vivo antidiabetic activty of Cissus pallida and Cissus vitegenia, BioMedRx 2013,1(5),469-
472.
44. R. Suthakaran A.Tamil Selvan, C. Jothibaskara Mohan, S. Karpagam Kumara Sundari,
Study on Role of Postmarketing Surveillance in New Drug Development, Asian J.
Management 4(1): Jan-Mar. 2013,12-15.
45. R. Suthakaran Anuradhabai Sandala,, Aparna Vema, A. Ravindernath, K. S. K. Rao
Patnaik, Molecular properties prediction, Docking studies, and synthesis of 5-benzimidazole-
1-yl- methyl –[1,3,4] oxadiazole-2-thiol and their derivatives. Intl. J. Res. Dev. Pharm. L.
Sci, 2(3), 2013,432-438.ISSN: 2278-0238.
46. R. Suthakaran, Srikanth, Kshemada Kappagantu, A. Tamil Selvan, S. B. Muthu Vadivel,
Synthesis and in vitro evaluation of novel urea derivatives as ACE inhibitors, BioMedRx
Vol.1 2013, 1(1),24-31.
47. R.Suthakaran, C.Krishna veni, S.Subramanyam, S.Raja, T.Srivalli, N.Sowmya sri,
S.Srikanth. Synthesis, Characterization and Antimicrobial Screening of 1-Suubstituted-3-
methyl-4-arylhydrazino-2-pyrazolin-5-ones and Isooxazolines. Int. J. Inno. Pharm. Res.
2011, 2(3), 156-60. ISSN: 0976-4607.
48. R.Suthakaran, P.Siddartha Kumar,S.Subramanyam, S.Raja, T.Srivalli, K.Yamini
.Synthesis, Characterization and pharmacological screening of 3-[5-substituted-1,3-
oxadiazole-2-yl]-2- methyl quinazoline-4(3H)-ones. Intl. Journal of Innovative
Pharmaceutical research, 2011,2(4) ,166-171.
10
49. R.Suthakaran, P.Raghavendra, G.Veena, G.Arun Kumar, E.Raj Kumar, N.Sangeetha,
B.Sirivennela, S.Smarani, H.Praneeth Kumar. Synthesis, Antioxidant and Antimicrobial
study of Novel Imidazolo Quinazoline Derivatives. Int.J.Chem.Anal. Sci. 2011; 2(6): 62-9.
ISSN: 0976-1209.
50. R.Suthakaran, M. Sailendra, S.Subramanyam, S.Raja, K.Yamini. Design of new
rivastigmine analogs based on molecular docking and binding free energy calculations- J.
Pharmacy Research-
51. R.Suthakaran, P.Raghavendra, G.Veena, G.Arun Kumar, E.Raj Kumar, N.Sangeetha,
B.Sirivennela, S.Smarani, H.Praneeth Kumar. Microwave synthesis and anti-inflammatory
evaluation of some new imidazolo quinoline analogs. Ras.J.Chem.2011; 4(1): 91-102. ISSN:
0974-1496.
52. R.Suthakaran P. Bharath Rathna Kumar, S.Subramaniyan and K.Yamini. Synthesis of
some novel 1-H pyrazole derivatives and their antibacterial activity studies. Ras.J.Chem.
2011; 4(2): 400-4. ISSN: 0974-1496.
53. .R.Suthakaran, G.Nagarajan, V.Balasumramaniam,K.Suganthi and G.Velrajan. Synthesis
and antimicrobial activity of 8-(Methylene-2”, 3”-disubstituted benzoqu inazolo-4-one)-9,2-
(4‟)-disub stituted benzopyrano pyrazoles. Indian J.Hetero Chem. 2005; 14: 201-4. ISSN:
0971-1627.
54. .R.Suthakaran, G.Nagarajan, V.Balasumramaniam, K.Suganthi, M. Marikannan, and.
G.Velrajan. Synthesis and Antitumor Activity of 4‟-aryl/alkyl-2”- D-aldosugar Disubstituted
bis-imidazole derivatives. Indian J. Hetero Chem. 2005; 15:173-6. ISSN: 0971-1627.
55. R.Suthakaran, G.Somasekhar, Ch.Sridevi,M. Marikannan, K.Suganthi and G.Nagarajan.
Synthesis of Anti-inflammatory, Antioxidant and Antibacterial activity of 7-Methoxy
benzofuran pyrazoline derivatives. Asian J Chem. 2007; 19(5): 3353-62. ISSN: 0970-7077.
56. .R.Suthakaran, S.Kavimani and D.Venkappayya, Synthesis Anti-inflammatory and
antioxidant activity of 3 - (2-(4z) - 4 - substituted benzylidene-4, 5-dihydro-5-oxo-2-phenyl
imidazol-1-yl) ethyl)-6, 8- un / dibromo subtituted-2-substituted quinazoline-(3H)-one,
Int.J.Pharmco.Bio.Sci. 2008; 2(2):29-36. ISSN: 0973-6808.
11
57. R.Suthakaran, k. Balaji, A. Naidu Ch,sridevi, Antimicrobial Evaluation and Synthesis of
Some Phenylpyrazolo benzothiazolo quinoxaline Derivatives, E-J.Chem.,2009, 6(3), 866-
870. ISSN: 0973-4945
58. Chaitanya Prasad K*, Prabodh M , Ashish S, Suthakaran R, Concept of 505 (b) (2)
application: benefits and challenges, international journal of drug regulatory affairs; 2014,
2(2), 16 – 20 issn: 2321 - 6794
59. R.Suthakaran, S.Kavimani, D.Venkappayya, A.Naidu, K.Balaji and Ch.Sridevi ,
Synthesis and biological evaluation of some indoquinaxaline pyrazolines., Ras. J. Chem.
2008; 1(2): 306-314. ISSN: 0974-1496.
60. R.Suthakaran, S.Kavimani,D.Venkappayya, Farhat sakina and K.Suganthi, Inflammation:
Synthesis and pharmacological investigation of some new 4(3H)-quinazolone Analogs as
antioxidant, antihistaminic, anti-inflammatory and antitumor agents. Ras. J. Chem. 2008;
1(2): 263-275. ISSN: 0974-1496.
61. R.Suthakaran, M.Bhagavan raju S.Kavimani,D.Venkappayya, Rajesh kumar,Ch.Sridevi,
C.Ratnamani and K.Suganthi. Synthesis, antioxidant, anti-inflammatory, antimicrobial
activities of 2-[(5-substituted aryl-1-„-N-substituted aryl amino methyl)prrazol-3-yl]
benzofuran. Ras. J. Chem. 2008; 1(1): 39-45. ISSN: 0974-1496.
62. R.Suthakran, S.Kavimani,D.Venkappayya, P.Jayasree, V.Deepthi, Fouzia Tehseen and
K.Suganthi. Microwave Assisted rapid synthesis and antimicrobial activity of 4-
oxothiozolidene derivatives. Ras. J. Chem. 2008; 1(1): 30-38. ISSN: 0974-1496.
63. R.Suthakaran, S.Kavimani ,D.Venkappayya and K.Suganthi, Synthesis and Anti-
microbial activity of 3 - (2-(4z) - 4 - substituted benzylidene-4, 5-dihydro-5-oxo-2-phenyl
imidazol-1-yl) ethyl)-6, 8- un / dibromo subtituted-2-substituted quinazoline-(3H)-one,
Ras.J.Chem 2008;2(2):29-36.ISSN: 0973-6808.
64. .R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo
benzimidazolo quinoxaline derivatives. Int. J. PharmTech Res. 2009; 1(3): 816-21. ISSN:
0974-4304.
12
65. R.Suthakaran, K.Balaji and Ch.Sridevi, Antimicrobial Evaluation and Synthesis of Some
Phenylpyrazolo benzothiazolo quinaxaline derivatives, E-J. Chem., 2009; 6(3): 866-70.
ISSN: 0973-4945.
66. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi, Antioxidant and antiinflammatory
activity of some phenylpyrazolo benzimidazolo quinoxaline derivatives, J.Pharm
Res.2009;2(9):1370-2. ISSN: 0974-6943.
67. R.Suthakaran, K.Balaji and Ch.Sridevi, Antioxidant, antiinflammatory and
Antihistaminic activities of some Phenylpyrazolo benzothiazolo quinoxaline Derivatives, Int.
J. Chem. Sci., 2009; 7(2): 1117-26. ISSN: 0972-768
68. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo
benzimidazolo quinoxaline derivatives Oriental J.Chem. 2009; 25(2):325-8. ISSN: 2231-
5039.
69. R.Suthakaran, S.Kannan,S.Aravinth vijay Jesuraj, E.Sam Jeeva Kumar, K.Saminathan,
M.Ravikumar and B.Parimala Devi, Wound healing activity of Mimosa pudica Linn
formulation. Int. J. PharmTech Res. 2009; 1(4): 1554-58. ISSN: 0974-4304.
70. R.Suthakaran, Sudha parimala,Ch.Shashidhar, Ch.Sridevi,and V.Jyothi,
Antiinflammatory activity of Celastrus paniculat.us seeds,Int. J. PharmTech Res. 2009; 1(4):
1326-9. ISSN: 0974-4304.
71. R.Suthakaran, V.Balasubramaniam, D.Shashank, T.Viswanath, Arif Pasha, V.Nagendra,
P.Perumal, Synthesis and Characterization of benzothiazole derivatives, Int. J. ChemTech
Res. 2009; 1(4): 1224-1231. ISSN: 0974-4290.
72. R.Suthakaran,K.Balaji,A.Naidu and Ch.Sridevi, Antioxidant and antiinflammatory
activity of some phenylpyrazolo benzimidazolo quinoxaline derivatives. E-J. Chem.,
2010; 7(1): 234-38. ISSN: 0974-6943.
73. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo
benzimidazolo quinoxaline derivatives as a potent antimicrobial agents. J.Chem.Pharm.Sci.
2010; 1(3): 13-6. 0974-4304.
13
74. R.Suthakaran, D.Shashank V.Balasubramaniam, ,E. Naveen kumar, V.Sriram,
V.Padmini, T.Lathasri, Synthesis and Characterization of benzothiazole derivatives, Int. J.
Appl. Chem., 2010; 6(2): 169-75. ISSN: 0973-1792.
75. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana,
Visible spectrophotometric methods for the determination of drotaverine hydrochloride in
bulk and pharmaceutical formulations., Int.J.PharmTech. Res. 2010; 2(3): 1787-91. ISSN:
0974-4304.
76. R.Suthakaran,G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B.Satyanarayana.
Formulations Quantitative Determination of Bisoprolol Fumarate in Bulk and Pharmaceutical
Dosage Forms by Spectrophotometry. International Journal of Chemical Sciences-2010;
6(2): 169-75.ISSN: 0972-768X (5)
77. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana.,
Visible Spectrophotometric Determination of Rosvastatin in Bulk and Pharmaceutical
formulations. Oriental J. Chem. 2010; 26(2): 589-93.ISSN: 2231-5039.
78. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana.,
Quantitative determination of bisoprolol fumarate in bulk and pharmaceutical dosage forms
by spectrophotometry. Intl.J.Chem.Sci , 2010,8(4),2253-2258, ISSN: 0972-768X.
79. R.Suthakaran, P.Raghavendra, G.Veena, G.Arun Kumar, E.Raj Kumar, N.Sangeetha,
B.Sirivennela, S.Smarani, H.Praneeth Kumar. Microwave synthesis and anti-inflammatory
evaluation of some new imidazolo quinoline analogs. Ras. J. Chem. 2011; 4(1):91-102.ISSN:
0974-1496.
80. R.Suthakaran. The assessment of current regulatory guidelines for biosimilars-A global
scenario. JPR online. 2014; 8(1): 49-52. ISSN: 0974-6943.
81. Ch. Srinivas reddy, G.Babu, R,Suthakaran et al. formulation and evaluation of esopiclone
film coated immediate release tablets by direct compression method was published in
International organization of scientific Research. ISSN: 2250-3021. (Accepted)
14
82. Ch. Srinivas reddy, G.Babu, Kusuma pravalikka, R.Suthakaran et al. Formulation and
evaluation of Rifampicin fast dissolving tablet was published in World J of Pharmacy and
Pharmaceutical Sciences. ISSN: 2278-4357. (Accepted)
83. Ch. Srinivas reddy, G.Babu, Kusuma pravalikka, R.Suthakaran et al. Formulation and In-
vitro evaluation of Lansoprazole Colon targeted drug delivery system. World J of
Pharmaceutical research. ISSN: 2277-7105. (Accepted)
84. Ch. Srinivas reddy, G.Babu, R,Suthakaran. Phytochemical and Pharmacological
Investigations of Cardiospermim halicacabum and Gymnema sylsvestre. World J of
Pharmacy and Pharmaceutical sciences. ISSN: 2278-4357. (Accepted)
85. Raju manda, R.suthakaran et al. Formulation and evaluation of bilayered tablets of
loperamide Hcl and Simethicone. International J of Pharmaceutical science and Research.
2014; 3(10): 204-208. ISSN: 0975-8232.
86. A.Tamilselvan, R.Suthakaran et al. purgative activity of caesalpinia pulcherrima sw
leaves extracts. Research J of pharmacology and pharmacodynamics. 2013; 5(3): 164-165.
87. A.Tamilselvan, R.Suthakaran et al. Gastroprotective activity of Tephrosia purpurea.
International J Res Ayurveda Pharm. 2013; 4(5): 1-5.
88. A.Tamilselvan, R.Suthakaran et al.antiurolithiatic activity of triphala karpa chooranam. J
Adv Pharm Edu and Res. 2013; 3(3): 267-272.
89. A.Tamilselvan, R.Suthakaran et al. Role of copyright in the protection of design. Int J
pharm Sci Rev Res. 2013; 22(2): 331-332.
90. A.Tamilselvan, R.Suthakaran , Anxiolytic effect of medicago sativa seeds extract on
rodents. Indo American journal of pharmaceutical sciences. 2014; 4(1): 406-415.
91. Raju manda, R.suthakaran et al. formulation of herbal hydrogels for wound healing
activity by using vitis vinifera seeds extract. Indo American journal of pharmaceutical
research. 2014; 4(10): 3940-3944. ISSN: ISSN: 2231-6876
15
92. Raju manda, R.suthakaran et al. Design, fabrication and invitro evaluation of irbesartan
and simavastatin bilayered tablets. Journal of pharma research. 2014; 3(10): 198-203. ISSN:
2319-5622.
93. Raju manda, R.Suthakaran .Design and invitro evaluation of colon targeted oral matrix
tablets of mesalamine for the treatment of inflammatory bowel diseases. Indo American
journal of pharmaceutical research. 2014; 4(10): 3929-3934. ISSN: 2231-6876.
94. Raju manda, R.suthakaran et al. Design and invitro evaluation of transdermal drug
delivery system for aspirin. Journal of pharma research. 2014; 3(10): 194-197. ISSN: 2319-
5622.
95. Raju manda, R.suthakaran et al. Refinement of solubility of poorly water soluble drug
celecoxib by employing solid dispersion technique. Journal of scientific research in
pharmacy. 2014; 3(4): 131-134. ISSN: 2277-9469.
96. Gandla kumaraswamy, R.suthakaran et al. Simultaneous estimation of sertraline and
alprazolam in its bulk and pharmaceutical dosage form by RP_HPLC method. World journal
of pharmacy and pharmaceutical sciences. 2014;3(11): 1005-1014. ISSN: 2278-4357.
97. Gandla kumaraswamy, R.suthakaran et al. development and validation of RP-HPLC
method for simultaneous estimation of irbesartan and simvastatin in tablet dosage form.
American J of Pharmacy and health research. 2014; 2(10): 200-205.ISSN: 2321-3647.
98. B. Himaja, Vijusha M. and R. Suthakaran ,Hepatoprotective activity of different extracts
of aerial parts of limnophilla indica by using CCl4 induced model. Der Pharmacia Lettre,
2014, 6 (5):78-83. ISSN: 0975-5071.
99. K. Veeresh, V. Manasa, Vijusha M. and R. Suthakaran .Antidiarrhoeal activity of
methanolic extract of justica procumbens by castor oil and enterpooling induced methods in
rats. Scholars research library. Der Pharmacia Lettre, 2014, 6 (5):121-129. ISSN: 0975-5071.
100. M. Mamatha, V. Manasa, M. Vijusha*, R. Suthakaran Hepatoprotective activity
of methanolic leaves extract of rostellularia procumbens by using CCl4 intoxicated rats.
16
International Journal of Basic & Clinical Pharmacology, November-December 2014 ; 3(6):
964-969. ISSN: 2219-2003.
101. Dr. R. Suthakaran*, J.Baloji Naik, International journal of pharmacy, 2016,
Method Development and Validation for Simultaneous Estimation of Citicoline and
Piracetam by RP-HPLC in Bulk and Combined Dosage forms.ISSN: 2249-1848 (accepted)
102. Dr. R. Suthakaran* World journal of pharmaceutical research, 2015, volume 5,
Issue 1, 322-336. BRICS- An Emerging Nations And Its Recent Pharmaceutical Outlook
(2015) . ISSN:2277-7105
103. R. Suthakaran* World journal of pharmaceutical research, 2015, volume 5, Issue
1, 277-291. EMA AND FDA -Adaptive Clinical Trials Design . ISSN:2277-7105
104. R. Suthakaran* world journal of pharmaceutical research, 2015, volume 5, Issue
1, 656-676, Method Development And Validation For Simultaneous Estimation Of
Esomeprazole And Domperidone By RP-HPLC In Bulk And Combined Dosage Forms.
ISSN:2277-7105
105. R.Parthibarajan*, J.Anuradha, T.Hurmath Fathima and R.Suthakaran;
Formulation And Evaluation Of Transdermal Gel Of Hyoscine Hydrochloride. world journal
of pharmacy and pharmaceutical sciences, 2015, volume 5, Issue, 1178-1200. ISSN:2277-
7105.
106. Kumaraswamy. Gandla*, R. Suthakaran, Sadhana. Bommakanti, R. Lalitha. Asian
J. Pharm. Ana. 2015; Vol. 5: Issue 3, 115-118 Development and Validation of RP-HPLC
Method for Simultaneous Estimation of Albendazole and Praziqantel in Tablet Dosage Form.
ISSN:2231-5667.
107. T. Srinivasa Rao*, S. Kavimani, S. Sudhakaran, P. Veeresh Babu International
Journal of Phytopharmacology. 6(4), 2015, 235-245. Ameliorative Role Of
Hypocholesterolemic Drugs In High Fat Diet Induced Amnesia In Rats .ISSN:0975-9328.
17
108. T. Srinivasa Rao*, S. Kavimani, S. Sudhakaran, P. Veeresh Babu ; International
Journal of Biological & Pharmaceutical Research. 2015; 6(12): 991-1000. Nootropic Effect
Of Hypocholesterolemic Drugs In Scopolamine Induced Amnesic Rats .ISSN:0976-3651.
109. R.Suthakaran, Evaluation of safety and efficacy of fixed dose combination of
telmisartan 20mg and amlodipine besylate with atenolol/amlodipine combination for the
treatment of essential hypertension. World journal of pharmaceutical research
.2016;5(2):54-71. ISSN:2277-7105.
110 R. Suthakaran, Kadiri Sunil Kumar, CH. Mamatha, N. Deepika, B. Sai Sushma,
Effects of Dietary Food Ingredients on Recognition Memory by using
Object Recognition Test in Mice, Research Journal of Pharmacology and Pharmacodynamics.
9(2): April-June, 2017, ISSN 0975-4407
111 R. Suthakaran , Parthibarajan, M. Vineela bhargavi, Raju manda, Drug policies, guidelines,
acts and regulations in republic of south africa , journal of Pharma research
Vol. 6, issue 3, 2017 ISSN: 2319-5622
112 Evaluation of analgesic potential of Boerhavia diffusa roots in albino mice
Kadiri Sunil Kumar, V. Saideepthi, Shaik Shahajeb, M. Nandini, R.Suthakaran, Research
Journal of Pharmacognosy and Phytochemistry. 9(2): April- June, 2017.
113 R. Suthakaran , Kumanan, M. Ramesh, SK. Jaffar, Raju manda, Journal of Scientific
Research in Pharmacy, vol. 6, issue 3, 2017 ISSN: 2277-9469, Preclinical and clinical trial
regulations in INDIA, USA and Europe
114. Suthakaran R ,Sudheer Kumar Dokuparthi, Md Amer Khan, Anusha A, Mashma Bee,
Shaibaz, Shaik Shahajeb, Sunil Kumar K, Acute oral toxicity study of Tectona grandis Linn.
methanolic seed extract in albino mice The Journal of Phytopharmacology 2017; 6(3): 183-185
18
115 R. Suthakaran *, Parthibarajan , K. Vanaja, Raju Manda, Risks and Opportunities in
development of new drug and question based review of regulatory compliance . Journal of
Pharma Research ,Vol. 6, Issue 3, 2017 ISSN: 2319-5622
116 R.Suthakaran *, Raju.Manda, K.Sunil Kumar, M.Ramesh and K.AparnaICH guidelines of
manufacturing and quality assurance of drugs and Cosmetics, Int. J. of Pharmacy and Analytical
Research Vol-6(4) 2017 [605-617]
117 R. Suthakaran, Kadiri Sunil Kumar*, S. Mounica, Rajesh Behera, K. Vijay Kumar,
Y. Shanmukh Sai, Cognitive Enhancing Effect of Murraya koengii Leaves by Radial Arm
Maze Test in Rats Research Journal of Pharmacology and Pharmacodynamics. 8(2): April -June,
2016
118 R.Suthakaran *, DVRN Bikshapathi , M.Ramesh , T. Ramya Sree ,Raju Manda,
Drug approval process and safety recall procedures in therapeutic goods administration
Australia, Pharmacreations | Vol.4 | Issue 4 | Oct- Dec - 2017 1-13
119 Suthakaran R et al / Int. J. of Pharmacy and Analytical Research Vol-6(4) 2017 [635-644]
Regulatory affairs on health Canada
120 Suthakaran R Kadiri Sunil Kumar*, Aneesha Unnisa, K. Sai Sushmitha, Ashish Lokhande
Antidepressant Activity of Cardamom oil by Marble Burying test in rats, Der Pharmacia
Lettre, 2016, 8 (3):279-282
121 R. Suthakaran1,Sujatha Banavath*1, Ragya Eslavath1, Ch. Yella Reddy1, , J. Shiva1, U.
Ramakrishna1 and Goli. Venkateshwarlu1, FORMULATION DEVELOPMENT AND
EVALUATION OF RIZATRIPTAN BENZOATE ORAL DISINTEGRATING TABLETS,
World Journal of Pharmaceutical Research ,Volume 7, Issue 16, 1897-1906. ISSN 2277– 7105
122 CH. Shankar1, D.V.R.N. Bhikshapathi2, R. Suthakaran3, CH. Pavani Padmaja4, Amtul
Wahab5 Development and validation of RP-HPLC method for ritonavir in bulk and
pharamceutical dosage forms , Int. J. of Pharmacy and Analytical Research , |Vol.7 |
Issue 2 | Apr - Jun -2018
123 Shriya N*, Jyothi V , Suthakaran Raj, Shankar CH, Bhikshapathi D.V.R.N., Recent Approaches of Impurity
Profiling In Pharmaceutical Analysis ,Journal of Innovation in Pharmaceutical Sciences (2018);2(1): 37-44
19
124 Shankar CH*, Suthakaran R and Prem Kumar B, A New RP-HPLC Method Development and Validation for the
Simultaneous Estimation of Febuxostat And Ketorolac in Bulk and Tablet Dosage Form
Int J Biomed Investig; Vol: 1; Issue 2 ,2018
125 Suthakaran R*1, Bikshapathi DVRN1 and Suthaparimala2 ,
RP HPLC Method Development and Validation for Quantitative Estimation of Tiotropium Bromide and Oldaterol ,
Int J Biomed Investig; Vol: 1; Issue 1,2018
126 Suthakaran R1*, Shankar CH1 and Sudha Parimala2, A New analytical method development and validation of
Ambroxol, Montelukast and Levocetirizine in Tablet dosage form by RP-HPLC method ,
Int J Biomed Investig; Vol: 1; Issue 1,2018
127 ) Suthakaran R et.al., Formulation development and invitro evaluation of zolmitriptan mouth dissolving tablets ,
world journal of advance healthcare research volume 2, issue 5. 2018
128) Suthakaran R et.al Formulation development and evaluation of candesartan cilexetil immediate release tablets ,
world journal of pharmacy and pharmaceutical sciences ,sjif impact factor 7.421 volume 7, issue 10, 1382-1392
research article issn 2278 – 4357
129) Suthakaran R et.al Formulation and in vitro evaluation of gastro retentive floating tablets of glipizide , world journal
of pharmaceutical and medical research, , 2018,4(10), 139-145,
130) Suthakaran R et.al Method development and validation for simultaneous determination of isoniaizid and atazanavir
in pure and pharmaceutical formulation by using HPLC, Asian journal of pharmaceutical analysis. 8(4): october -
december, 2018
131 ) Suthakaran R, el.al., Invitro wash- off comparission studies of metronidazole mucoadhesive microspheres using
different polymers , european journal of pharmaceutical And medical research,
ejpmr, 2018,5(9), 474-477
132) R. Suthakaran et al., A Review on Pyrones, Pyrone derivatives and their biological activity, volume 8, issue
2,2019,442-450, World journal of pharmacy and pharmaceutical sciences,
133) R. Suthakaran et al., A new validated RP-HPLC method for determination of ciprofloxacin and ornidazole in bulk
pharmaceutical dosage forms. European journal of biomedical and pharmaceutical sciences. 2019
volume: 6 issue: 2 year: 2019, 386-392.
Publications Under process Pharmaceutical
analysis
20
1 ASSAY METHOD DEVELOPMENT AND MINIVALIDATION OF LINAGLIPTIN AND METFORMIN IN IMMEDIATE
RELEASE TABLETS
2 METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION
OF ISONIAIZID AND
ATAZANAVIR IN PURE AND PHARMACEUTICAL FORMULATION BY USING HPLC 3 A SIMPLE RP – HPLC METHOD DEVELOPMENT AND VALIDATION OF IBUPROFEN AND TRAMADOL IN
PHARMACEUTICAL DOSAGE FORM
4 A NEW RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS
ESTIMATION OF
FEBUXOSTAT AND KETOROLAC IN BULK AND TABLET DOSAGE FORM
5 Method development and validation for the simultaneous stimulation of trifloperezine and isopeopamide in
tablet dosage form by RP HPLC
6 DEVELOPMENTANDVALIDATION OFASIMPLEANDRAPIDRPHPLCMETHODFORTHE ESTIMATIONOFNEVIRAPINEIN
BULKDRUGANDTABLET DOSAGEFORM
7 A NEW ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF AMBROXOL,MONTELUKAST AND
LEVOCETRIZINE IN TABLET DOSAGE FORM BY USING RP-HPLC METHOD
8 ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ATAZANAVIR SULFATE CAPSULES BY RP-HPLC
9 RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF
LOSARTAN
POTASSIUM AND AMLODIPINE BESYLATE IN TABLET DOSAGE FORM
10 METHOD DEVELOPMENT AND VALIDATION of etodolac and thiocolchicoside in combiined
tablet dosage form by RP HPLC
11 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF
AMBROXOL AND DESLORATADINE
12 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF KETOROLAC TROMETHAMINE AND MOXIFLOXACIN HCl
analytical method development and validation for cilnidipine and metoprolol succinate in
pharmaceutical formulation and biorelevant dissolution media by chromatographic tecnique
13 ANALYTICALMETHOD DEVELOPMENT AND VALIDATION OF
ATENOLOL&CHLORTHALIDONWITHITSKNO
WNANDUNKNOWN IMPURITIES BY FORCED DEGRADATION STUDY IN ITS SOLID DOSAGE
FORM BY RP-HPLc
14 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF
IBUPROFEN AND PSEUDOEPHEDRINE
15 A VALIDATED RP-HPLC METHOD FOR ESTIMATION OF TELMISARTAN AND METOPROLOL
IN ITS BULK FORM
16 ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR NIMESULIDE AND
RACEMETHIONINE IN
COMBINE DOSAGE FORM BY RP-HPLC
17 Reverse Phase High performance Liquid Chromatography method for Simultaneous
estimation of Esitalopram and Flupentixol in pure and marketed formulation.
18 METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANIOUS ESTIMATION OF
TIOTROPIUM BROMIDE AND OLODATEROL BY USING RP HPLC
19IMULTANEOUS ESTIMATION OF CLINIDIPINE AND CHLORTHALIDONE BY RP-HPLC
SPECTRUM INDEX BASED STABILITY INDICATING METHOD DEVELOPMENT AND
VALIDATION
FOR DETERMINATION OF VARIOUS PROTON PUMP INHIBITORS AND DOMPERIDONE ….BY
HPLC
20 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF NEVIRAPINE IN BULK AND
TABLET FORMULATION
METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL
FORMULATION AND BIORELEVANT DISSOLUTION MEDIA BY CHROMATOGRAPHIC TEC
Pharmaceutical regulatory affairs
19
20
21 CURRENT REGULATIONS FOR CLINICAL TRIALS FOR USA AND INDIA
interrelation between regulatory affairs,quality control and quality assurance for
regulatory submission as per ICH guidelines
22 cGMP regulations and ANDA filing process for USFDA
23 PRINCIPLES OF REGULATORY COMPLAINCE AND ROLE OF REGULATORY AFFAIRS IN HEALTH CANADA
24 MARKET PRINCIPLE OFREGULATORY COMPLIANCE (PRC)AND ROLEOFREGULATORYAFFIRSONHEALTHCANADA
25 LATEST TRENDS IN REGULATORY COMPLIANCE TRAINING AND DRUG APPROVAL IN MEDSAFE, NEW ZEALAND
26 current trends in liaison with regulatory authorities and EU DMF
27 CURRENT TRENDS IN REGULATORY PROJECT MANAGEMENT AND REGULATORY DOSSIER OF TOP TEN COMPANIES
28 PHARMACOPOEIAL STANDARDS FOR API & IND, NDA, ANDA APPROVAL PROCESS DURING 2010-2015 FROM USA
29 IND, NDA, ANDA APPROVAL PROCESS DURING 2010-2015 FROM USA
30 Product registration strategies, patent filing to India&USA
31 Product registration strategies, patent filing to India, USA & EU. Current appraisal procedures for
new regulations, standards, policies and guidance issued by Regulatory authorities by India, USA and EU
32 current regulations for various filing for the quality audits, registered products of JAPAn , SOUTH KOREA and CHINA
PROPOSAL FOR REDUCE (RT) OR SKIP TESTING (ST) AT IN-PROCESS SPECIFICATION BASED ON
ANNUAL PRODUCT REVIEW (APR)
33REGULATORY ASPECTS OF CONTRACT MANUFACTURING AND GMP REGULATIONS IN INDIA, USA AND BRAZIL
34 Electronic common technical documentation data submission to USFDA and INDIA
35 REGULATORY ISSUES FOR IMPORT, EXPORT AND DRUG APPROVAL OF LATIN AMERICAN COUNTRIES
COMMERCIALASPECTSOFREGULATORYAPPROVALSAND REGULATIONSING8COUNTRIES
LIST OF SEMINARS AND CONFERENCE
PAPER PRESENTATIONS
1. PRESENTED A PAPER IN WORLD CONFERENCE ON DISASTER
MANAGEMENT INFRASTRUCTURE AND CONTROL SYSTEMS DMIC 10-12
NOVEMBER 2003, HYDERABAD.
21
2. PRESENTED A PAPER IN NATIONAL WORKSHOP ON CLEANER
TECHNOLOGIES FOR SUSTAINABLE DEVELOPMENT HELD AT INSTITUTE OF
SCIENCE AND TECHNOLOGY JNTU ON 27TH -28TH SEPTEMBER 2005,
TWO DAY NATIONAL SMEINAR ON EMERGING TRENDS IN THE SYNTHEITC
ASPECTS OF MEDICINAL CHEMISTRY 28-29TH OCT 2005 UCPS, KAKATIYA
UNIVERSITY WARANGAL
3. Preliminary phytochemical investigation and antibacterial activity of bark and leaves of
Barrigtonia actntangal linn.
4. Synthesis and biological evaluation of some novel benzofuran pyrazoles.
5. Pharmacological evaluation of single and mixture drugs for antidiabetic activity.
UGC SPONSORED NATIONAL CONFERENCE ON CURRENT RESEARCH TRENDS
AND DEVELOPMENTS IN HETERO CYUCLIC CHEMISTRY 17, 18 MARCH 2006.
6. Synthesis and biological evaluation of some novel 2,3 disubstituted 1,3 quinazoline 4
one.
7. Design synthesis, anti-inflammatory and antimicrobial activity of 2-2 di substituted
methyulene 3,5 di phenyl pyrazoline 1 phenyl 2 acetyl 3 methyl pyrazoline 5 one.
8. Antidiabetic – a comparative studies with mixture and single drugs
INDIAN PHARMACY GRADUATES ASSOCIATION 23RD ANNUAL CONFERENCE
(4TH AND 5TH NOVEMBER 2006, CHENNAI). THEME: GLOBAL TRENDS IN PHARMA
OPPORTUNITIES AND CHALLENGES.
9. Poster presentation on PPC31. Synthesis of anti-inflammatory, antioxidant and
antibacterial activity of 7-methoxy benzofuran pyrazoline derivatives.
10. Poster presentation on synthesis and screening of anticonvulsant and antitubucular
activity of new 2-((methylene substituted amino)-3-(o-dicholorphenyl)4-amino
triazine))6,8 dibromo 3H quinazoline -4-one derivatives.
UGC CELL-OU AND TEQIP SPONSORED NATIONAL SYMPOPSIUM ON CHEMISTRY
TECHNOLOGY INTERFACE A SYNERGISTIC APPROACH 30TH SEP 1,2ND OCT 2007.
11. Novel synthesis and antitumor activity of 7 hydroxyl 4 methyl coumarin derivatives
12. Chemopthrapy in the elderly phearmacologic considerations
13. Synthesis and neuro pharmacological activity of some quinoxaline derivatives.
14. Rheumatic fever and its management
15. Recent advancement in novel drug therapy system.
22
16. WON A SECOND PRICE IN POSTER DAY-I IN AURORA‟S TECHNOLOGICAL
AND RESEARCH INSTITUTE ON AERO BIO NANO 2007 HELD AT 29TH AND
30TH MARCH2007.
17. PRESENTED A PAPER IN 9TH NATIONAL CONFERENCE ON ASSOCIATION
FOR PREVENTION AND CONTROL OF RABIES IN INDIA (APCRI) ON JULY
2007.
18. PRESENTED A POSTER IN NATIONAL SYMPOSIUM ON CHEMISTRY
TECHNOLOGY INTERFACE: “A SYNERGISTIC APPROACH” HELD AT NIZAM
COLLEGE OF TECHNOLOGY, O.U, HYDERABAD ON 30TH SEPTEMBER -2ND
OCTOBER 2007.
19. PRESENTED A POSTER IN 60th IPC NEW DELHI ON ANTICARCINOGENIC
ACTIVITY AN ANTIMICROBIAL ACTIVITY OF MOMORDICA FROSVENORI ON
DECE 12 TO 14TH 2008.
AICTE SPONSORED NATIONAL LEVEL SEMINAR ON APPLICATIONS OF
BIOSTATISTICS IN PHARMACEUTICAL SCIENCES ON AUG 16-17 2009 ORGANISED
BY JAYAMUKHI COLLEGE OF PHARMACY,NARSAMPET, WARANGAL.
20. Phytochemical and pharmacological review of Ageratum conyzoides.
21. QSAR analysis on α-carboline as antitumor agent
22. Wound healing activity of the leaf extracts and deoxyelephantopin isolated from
Elephantopus scaber linn.
23. Antitumor activity of biflavonoides from Ouratea and Luxemburgia on human cancer cell
lines.
24. Antitumor studies with extracts of Calotropis procera root employing HEP2 cells and
their possible mechanisms of action.
25. Pharmacokinetics of one daily in busulfan as part of pretransplantation preparative
regimens: a comparison with an every 6 hour dosing schedule.
26. Organosilicon containing thiazole derivatives as potential lipoxygenase inhibitors and
antiinflammatory agents.
27. Convenient synthesis of 1-substituted -4- methyl -5- oxo triazolo quinazolines.
28. Evaluation of anti asthmatic activity of curculigo orchioides rhizomes.
29. Synthesis and pharmacological investigation of novel 4-(3-ethyl phenyl)1- substituted 4H
(1,2,4) triazolo (4,3-A) quinazolin-5-ones as a new class of antihistaminic agents
30. Invitro antibacterial activity of ten series of substituted quinazolines.
31. Synthesis, antiviral and cytotoxic activities of some novel 2-phenyl 3 disubstituted
quinazolin 4 ones.
32. Synthesis, characterization and in vitro antifungal evaluation of novel benzimidazolo
quinazolines
23
33. Synthesis of some new quinazoline analogs and their antimicrobial activity.
34. Synthesis of some new quinazolin 4 one derivatives and evaluation of their antimicrobial
and anti-inflammatory effects.
35. Analysis of heavy metals in waterm sediments and fish samples of madivala lakes of
Bangalore.
36. Antiinflammaorty and analgesic activity of Balanites aegyptiaca in experimental animal
models.
37. Antimicrobial activity of blue green anad green algae
38. HPLC studies on the targeting efficiency of etoposide immune conjugates on EAC
induced cancer in mice.
39. Development and evaluation of hepatitis B antigen loaded PLGA microspheres for single
shot vaccination.
40. Community pharmacists as a medican in 2020.
41. Overview of clinical data management
42. Contribution of medical wastes to the total pollution level in jaunpur city
43. Awareness of pharmacy students regarding self medication
44. Role of clinical pharmacist in health care management.
45. First pass effects of verapamil on the intestinal absorption and liver disposition of
fexofenadine in the porcine model.
46. Inhibitor like activity in rat cerebrospinal fluid after stimulation by an aversive quinine
taste.
47. Rice based mucosal vaccine as a global strategy for cold chain and needle free
vaccination.
48. AIDS vaccine: present status and future challenges
49. Dental caries vaccine
50. In vivo evaluation of single dose tetanus toxoid vaccine formulation with chitosan
microspheres.
51. Rotavirus vaccines
52. Quadrivalent human papillopmavirus recombinant vaccine: the first vaccine for cervical
cancers
CIMAP GOLDEN JUBILEE NATIONAL SYMPOSIUM ON FUTURE TRENDS IN
MEDICINAL AND AROMATIC PLANTS TECHNOLOGIES AND STRATEGIES. 17TH
NOV 2009.
53. Isoquinoline alkaloids as pro-antioxidant and 12-LOX inhibitor im mahonia aquifolium
extract.
54. Antibacterial and wound healing activity of roots of Sesamum indicum.
55. Anti-inflammatory activity of Delonix elata.
1st NATIONAL LEVEL SEMINAR DRAVYAKA 2010, 19 20 TH MARCH 2010 AT GEETHANJALI COLLEGE OF PHARMACY, HYDERABAD.
24
56. High performance liquid chromatography method for determination of diltiazem human
plasma.
APTICON-2010
57. Solid liquid nano particles containing nimesulide preparation, characterization and
cytotoxic studies.
58. Synthesis, characterization and antifungal activity of novel quinoline -4-one derivatives
containing 8-hydroxyl quinazoline liquid and its various metals complexes.
59. Synthesis and antimicrobial activity of quinoxaline based thiazolidines and azetidinones.
60. Synthesis, characterization and biological activity of various substituted benzothiazole
derivatives.
61. Anti-inflammatory activity of flowers of tabemarementana diresicata linn.
62. Development and validation of RP-HPLC method for the determination of adefair
dipivoxil in bulk and its pharmaceutical formulation
63. Optimisation of alkaline protease production from a mutant of alkalophylic bacillus
pantotheneticus using molasses a substrate.
ICODD THEME: EMERGING INNOVATIONS IN DRUG DELIVERY TECHNOLOGY 29-
30TH JANUARY 2010.
64. Formulation design of fast dissolving tablets of clonazepam by sublimation method.
65. Formulation and development of fast dissolving tablets contain solid dispersions of
felodipine.
66. Formulation and release studies of nimusulide solid dispersions.
67. Enhancement of dissolution rate of amperozide using solid dispersions with polyethylene
glycol.
68. Poly nanaoparticle based inhalable sustained drug delivery system for experimental
tuberculosis.
69. Simultaneous RP-HPLC determination of nimesulide and paracetamol in tablets
70. Respiratory tract drug delivery newer approaches for drug delivery to and via respiratory
tract.
NATIONAL SEMINAR ON REVENT ADVANCES IN ANALYTICAL SCIENCES INDIAN
PERSPECTIVE (RASSI) AT IICT, HYDERABAD 20,21ST –JAN 2011.
71. 31PNMR spectroscopy detects metabolic abnormalities in asymptomatic patients with
cardiac myopathy.
72. LC/MS analysis of N-terminal protein adducts with improved sensitivity. A comparison
of selected edman iso thiocynathate reagents.
73. A validated RP HPLC –PAD method for the determination of hedercoside with in
hivythyme cough syrup
74. New spectrophotomeric and fluorimetric methods for determination of fluoxetine in
pharmaceutical formulations
25
75. HPLC and anti-inflammatory studies of the flavanoid rich chloroform extract fraction of
Orthosiphon stamineus leaves.
76. HPLC, NMR and MALDI-TOF MS analysis of condensed tannins form Lithocarpus
glaber leaves with potential free radical scavenging activity.
TWO DAY NATIONAL CONFRENCE ON REFORMS AND INNOVATIONS IN
PHARMACY EDUCATION IJAPR ON 17-18 AUG 2012.
1. Non Erodible
Polymericmatrix Tablets Of Isoniazid Using Sintering Technique: Design And Invitro
Evaluation Of Matrix Tablet
2. Extended
Release Metformin Hydrochloride From Hydroxy Propyl Methyl Cellulose Matrices
Formulation And In Vitro - In Vivo Evaluation
3. Formulation Of
Sustained Release Ranitidine Tablets
4. Synthesis And
Antimycobacterial, Photosynthesis-Inhibiting, And Antialgal Activity Of Quinazoline-4-
Thiones
5. Microwaves for
Sol-Gel Synthesis Of Boron Carbide.
6. Conventional
And Microwave Assisted Synthesis And Qsar Studies Of Coumarinylchalcone Analogs
As Potent Antimicrobial Agents.
7. Lc-Ms/Ms Determination Of Bromperidol In Biological Matrices: Method Validation
And Forensic Application.
8. Design and invitro evaluation of colon targeted oral matrix tablets of Mesalamine for the treatment of inflammatory bowel diseases.
DRAVYAKA-2012 ON 15-14TH APRIL AT GITNJALI COLLEGE OF PHARMACY,
HYDERABAD.
77. Extra nuclear effects of thyroid hormones in skeletal muscle.
78. New targeted therapies for anaplastic thyroid cancer.
79. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons
from the recent clinical trials.
80. Therapeutic agents for alzheimer‟s disease.
81. Vinyl sulfoe containing parasitic cysteinyl protease inhibitors
82. Natural products: promising resources for cancer drug discovery
83. Targeting cancer using fragment based drug discovery
84. A QSAR study on some series of HIV -1 integrase inhibitors
85. Aspartate aminotransferase –bridging carbohydrate and energy metabolism in
plasmodium falciparum
86. Design, synthesis and antitumor activity of novel D-glucoronic acid derivatives
87. LC-MS/MS determination of bromperidol in biological matrices: method validation and
forensic application
26
88. Oxygen free radicals and their biomedical implications: A mini review
a. Potential anticancer properties of bisphosphonates : insights from preclinical
studies
89. Recent advances in the development of small molecule compounds targeting HIV-1 as
membrane fusion inhibitors
90. Synthesis,antimicrobial and anti inflammatory evaluation of substituted 1,2,4 triazole
analogs
91. Application of HPTLC and LC_MS methods of determination of topiramide in
pharmaceutical formulations
92. Methods for analysis of free radicals in cigarette smoke
93. Cancer nanotechnology: emerging role of gold nanoconjugates.
PHARMACONVENTION 2012 AT PADMAVATHI SCHOOL OF PHARMACY,
THIRUPATHI, A.P
94. Design of Rivastigmine based on molecular docking and binding free energy calculation.
CPER CURRENT STATUS AND FUTURE PROSPECTS IN PHARMACY EDUCATION
AND RESEARCH TOWARDS INDUSTRY APPLICATION 29-30TH NOV 2013.
95. Availability And Dispensing Practices For Antimalarials And Antimicrobials In Western
Kenyan Pharmacies
96. Non-Equivalence Of Antibiotic Generic Drugs And Risk For Intensive Care Patients.
97. Hold Time Stability Studies In Pharmaceutical Industry: Review
98. A planning model of pharmaceutical needs for mass gatherings at public special events.
99. The Development Of Intellectual Property Policies In Africa- Some Key
Considerations And A Research Agenda
100. Contribution of web for the research on pharmaceutical patents
101. Evaluation of the Learning Environment at the Faculty of Medicine, Suez Canal
University: Students? Perceptions
102. Growing Conflicts between Intellectual Property Rights and Health.
CMR COLLEGE OF PHARMACY, PHARMA INNOVATE 2K13. 27-28 DEC 2013.
103. Gastroprotective Activity of Plant Belongiing To Chrozophora Species.
104. Screening Of Skeletal Muscle Relaxant Activity Of Plant Vicia Faba
105. Procedure for drug approval in different coutries
106. Regulatory environment and clinical trials in south east asia.
107. A novel approach of fast dissolving oral films: a review
108. The role of regulatory GMP audit in pharmaceutical companies
109. Design and in vitro evaluation of gastroprotective valacyclovir HCL floating tablets
27
110. ANDA paragraph IV filings: a complete review
111. The common technical document: taking Indian NDA process towards globalization
112. Formulation and in vitro evaluation of fast disintegrating tablets of elitriptan HCL.
APTICON- 2013.
113. Legal protection of intellectual property : the changing attitude of US and its
influence on Taiwan.
114. Formulation development and evaluation of sustained release pellets of tramadol
HCL
115. The cumulative protection of designs in the European union and the role in such
protection of copyrights
116. PAY „n‟ PLAY : public performance of sound recordings VIS-À-VIS copyright
infringement.
117. PRESENTED A POSTER IN NATIONAL LEVEL SYMPOSIUM ON EMERGING
CHALLENGES AND TRENDS IN PHARMACY PROFESSION IN FUTURE AHEAD
HELD AT AVANTHI INSTITUTE OF PHARMACEUTICAL SCIENCES ON 8TH
APRIL 2013.
INDIAN COUNCIL OF MEDICINAL RESEARCH AND JSS UNIVERSITY, MYSORE. Sponsored TWO DAYS NATIONAL SEMINAR ON COMPUTER AIDED DRUG DESIGN
DISCOVERY OF NEW MOLECULES. (16th and 17th August 2013).
118. Synthesis and SAR studies of Praziquantel derivatives with activity against
schistoma japonicum.
119. A reassessment on quinazoline -2,4 (1H,3H)-dione as a substitute for thymine in
triple helix forming oligonucleotides.
120. Holographic quantitative strucuture activity relationship of tryptamine derivatives
at NMDA, 5HT 1A and 5HT 2A receptors.
121. Panduratin A, a possible inhibitor in metastasized A549 cells through inhibition of
NF-Kappa B translocation and chemoinvasio.
NATIONAL CONFERENCE ON EMERGING OPPURTUNITES OF CLINICAL TRIALS IN
HOSPITAL INDUSTRY. ROLE OF PHARMACIST IN ENSURING REGULATORY
COMPETANCE. NATIONAL CONFERENCE HELD AT MALLA REDDY MEDICAL
COLLEGE FOR WOMEN. HYDERABAD ON 1ST AND 2ND AUGUST 2014.
122. Nanogel-Based Delivery Of Mycophenolic Acid Meliorates Systemic Lupus
Erythematosus In Mice
28
123. Nano-Medicine Based Drug Delivery System
124. R-Dna Technology-Case Study
NATIONAL SYMPOSIUM ON CURRENT TRENDS IN PHARMACEUTICAL SCIENCES
ON 1ST MARCH 2014 BY ANWARUL ULOOM COLLEGE OF PHARMACY, NEW
MALLEPALLY, HYDERABAD.
125. Development & Evaluation Of Bilayer Floating Bioadhesive Tablets Of Repaglinide And Glipizide
126. Formulation Development And Evaluation Of Sustained Release Pellets Of
Tramadol Hydrochloride
127. Procedure For Drug Approval In Different Countries
128. Pharmaceutical Regulatory Affairs – Review
129. Regulatory & Patent Laws Of Drug Design, Safety And Environmental Aspects
Of G8 Countries
130. Gastroprotective Activity Of Celosia Argentea Leaf Against Stress Induced
Ulcers In Rats
131. Comparitive Profiles Of Neuromuscular Blocking Properties Of Leaves And
Seeds Of Plant Vicia Faba
132. Development And Validation Of Uv-Spectrophotometric Method For
Determination Of Torsemide In Tablet Dosage Form
Guidance Detail
M.PHARM THESIS
PHMNRA - MPHARM- PHARM MANG AND REGULATORY AFFAIRS-2012
S. NO H.T.NO NAME OF THE STUDENT CONTACT NUMBER
1
12Y61S1001
K NARESH
REGULATORY
REQUIREMENTS
FOR
PHARMACEUTICAL
PRODUCT
REGISTRATION IN
INDIA. 2014
2
12Y61S1002
K CHAITANYA PRASAD
NEW DRUG
APPLICATION (NDA)
APPROVAL AND
APPROVED DRUGS
OF FDA FROM 2010
TO 2013,
2014
29
3
12Y61S1003
DEVARAKONDA AJAY KUMAR
DRUG
DESIGN,MANUFACT
URING AND TOTAL
QUALITY CONTROL
MANAGEMENT OF
USA & INDIA 2014
4
12Y61S1004
KOLLURI SRINATH
. NDA DRUG
APPROVAL PROCESS
SINCE 2010 AND
DMF,DOSSIER OF
USF DA, 2014
5
12Y61S1005
BACHU SNIGDA
REGULATORY AND
INTELLENCTUAL
PROPERTY RIGHTS
DOCUMENTATION
IN INDIA & USA, 2014
6
12Y61S1006
KAYITHOJ SANTHOSH KUMAR
. COMPARISION OF KEY REQUIREMENTS
FOR THE REGISTRATION OF
GENERIC INJECTABLES IN
LATAM,BRAZIL&ME XICA, 2014
7
12Y61S1007
NYALAM AJUTESH BABU
NEW DRUG
APPROVAL PROCESS
OF E.U.JAPAN & COREA, 2014
8
12Y61S1008
KATIKANENI SHRAVYA
REGULATORY
DOSSIERS OF ASEM
COUNTRIES, 2014
9
12Y61S1009
AMANAGANTI KRANTHI KUMAR
IND & NDA DRUG
APPROVAL
PROCESS IN UNITED
STATES OF AMERICA
AND EUROPEAN
UNION, 2014
10
12Y61S1010
DEVAMADA SREEKANTH
REGULATORY
ASPECTS OF
PRECLINICAL
.CLINICAL &
PHARMACOVIGILAN
CE OF BRICS (BRAZIL,RUSSIA,IND
30
IA,CHINA,SOUTH
AFRICA)& USA. 2014
11
12Y61S1011
POLANGARI SWATHI
. REGULATION OF
PRECLINICAL
&CLINICAL TRIAL
APPROVAL PROCESS
IN ASEAN
COUNTRIES. 2014
12
12Y61S1012
B VARA PRASAD RAO
REGULATORY REQUIREMENTS FOR
GENERIC DRUG DEVELOPMENT IN
USA&EMEA MARKET, 2014
13
12Y61S1013
GONE SRIKANTH
IPR AND
REGULATORY
DOSSIER OF USA,
2014
14
12Y61S1014
SAMULA SAMATHA
ICH GUIDELINES &
DRUG APPROVAL
PROCESS OF SAARC COUNTRIES. 2014
15
12Y61S1015
M.PRABHODH
REGULATORY
AUDITS AND IPR
INSPECTIONS OF D8
COUNTRIES, 2014
16
12Y61S1016
MOHD VASEEVUR RAHMAN
COMPARITIVE
STUDY OF IPR IN
SAARC COUNTRIES
(INDIA,BANGLADES
H,BHUTAN,NEPAL,S
RILANKA,AFGHANIS
THAN,PAKISTHAN),
2014
17
12Y61S1017
ASHISH RAJENDRA KUMAR
REGULATORY AND
DOSSIER APPROVAL
PROCESS OF TOP 10
COMPANNIES IN
GLOBAL LEVEL, 2014
18
12Y61S1018
D.RASTRAPAL
REGULATORY &
PATENT LAWS OF
DRUG DESIGS &
SAFATY ,
31
ENVIRONMENTAL
ASPECTS OF G8
COUNTRIES. 2014
19
12Y61S1019
G.DILIP KUMAR
REGULATORY
LAWS,AUDITS,LITIG
ATIONS AND RISK
MANAGEMENT OF
G20 COUNTRIES. 2014
20
12Y61S1020
N.ASHOK KUMAR
REGULATORY
SYSTEMS AND
DOCUMENTATION
IN BRICS COUNTRIES
, QUALITY
ASSURANCE,PROCES
S VALIDATION AND
PHARMACOVIGILAN
CE STUDIES. 2014
PAQA
21
11Y61S0401
SHILPA EDUNOORU
Analytical Method
Development And
Validation Of
Indapamide And
Perindopril Erbumine
By
RP-HPLC Method In
Bulk And Tablet Dosage
Forms. 2013
22
11Y61S0416
N.CHIRANJEEVI
Bioanalytical Method
Development And
Validation For
Estimation Of Irbesartan
In Human Plasma Using
Irbesartan D4 Internal
Standard By Liquid
Chromatography And
Tandem Mass
Spectrometry Method, 2013
23
11Y61S0417
D.NARESH
RP-HPLC Method
development
and Validation for the
simultaneous
quantitative estimation
of Zolpidem Tartarate
32
and Melatonin in Tablets. 2013
24
12AD1S0401
G.MOUNIKA
METHOD
DEVELOPMENT AND
VALIDATION OF
CLOMIPRAMINATE
HYDROCHLORIDE
FLUVOXAMINE BY RP-HPLC METHOD
25
12AD1S0413
R.R.BANGARAMMA
METHOD
DEVELOPMENT AND
VALIDATION OF
SIMULTANEOUS
ESTIMATION OF
SAXAGLIPTIN AND
METFORMIN BY RP-
HPLC IN BULK AND
COMBINED DOSAGE FORMS
26
12AD1S0414
R.SRAVANI
A VALIDATED RP-
HPLC METHOD FOR
SIMULTANEOUS
ESTIMATION OF
HYDROCHLOROTHIA
ZIDE AND
QUINAPRIL
HYDROCHLORIDE IN
ITS BULCK AND
PHARMACEUTICAL
DOSAGE FORM
27
12AD1S0415
S.NAGA CHANDRIKA
A VALIDATED RP-
HPLC METHOD FOR SIMULTANEOUS
ESTIMATION OF FLUOXETINE
HYDROCHLORIDE AND OLANZAPINE IN
TABLETS
Pharmaceutical Chemistry
33
28
10AD1SO201
K.Balaraju
Method validation for
related substances in
telemistran in
telemistran tablets by
using RP-HPLC method,
2012
29
10AD1SO206
Pallavi vedire
Antidiabetic activity of
leaf extract of gymnema sylvestre in rats and
molecular docking of its gymnemic acid on
eNOS in diabetic humans, 2012
30
10AD1SO207
Rajendra Prasad.N
Molecular docking and
QSAR Studies of
Various phytochemicals
as drug targets against
lactate dehydrogenase of
plasmodium falciparum
in the treatment of
malaria
31
10AD1SO208
Raheem Pasha sheik
Phytochemicals of
Barleria cristata AND
Butea monosperrma AS
DRUG AGAINST
ASPARAGENYL t –RNA
SYNTHETASE Brugiya
malayi : AN IN –
SILICO APPROACH
32
10AD1SO209
Saritha devi N
METHOD
VALIDATION OF
VALACYCLOVIR
HYDROCHLORIDE
BY RP-HPLC-PDA METHOD
33
0406105
C.RATNAMANI
SYNTHESIS,
ANTIMICROBIAL
AND ANTI-
INFLAMMATORY
ACTIVITY OF 3-(2-
(17Z)-5-
SUBSTITUTED) -4‟- OXO -2‟-PHENYL,
34
IMIDAZOL-1‟-YL)-2-
SUBSTITUTED
METYL
/ARYL/CHLOROMET
HYL QUINAZOLIN-
4(3H)-ONES
34
04-05-102
K.BHAGYA LAXMI
CHEMICAL
INVESTIGATION OF
BOSWELLIA
SERRATA ROXB AND
PHOSPHOMOLYBDIC
ACID
(H3PMO12O4
0) CATALYSED SYSTHESIS OF
HANTZSCH 1,4-
DIHYDROPYRIDINES
AND β –ENAMINO
COMPOUNDS
35
10AD1SO101
T.ANITHA REDDY
EVALUTION OF
ANTI-
OXIDANT,ANALGESI
C AND ANTI-
INFLAMMTORY
ACTIVITIES OF A
HERBAL FORMULATION
36
11AD1S0201
G.AKILA
Synthesis,
Characterization and
Biological Evaluation of
Novel Pyrazoline
derivatives.
37
12AD1S0203
YEDLA RAJESHWARI
“Reverse vaccinology
approach for designing
vaccine against
syphilis”
38
12AD1SO416
NIHARIKA SRIDASAM
Analytical Method
Development and
Validation of
Bendamustine
Hydrochloride by RP-
HPLC in API and
Pharmaceutical Dosage
Forms
39 12AD1S0408 M.DIVYA “SIMULTANEOUS
35
ESTIMATION OF
SERTRALINE AND
ALPRAZOLAM IN ITS
BULK AND
PHARMACEUTICAL
DOSAGE FORM BY
RP-HPLC METHOD”
40
12AD1S0108
K.SHALINI
WOUND HEALING
ACTIVITY OF
METHANOLIC
EXTRACT OF
LEAVES OF
PEDALIUM MUREX IN
VARIOUS MODELS
HTNO PROJECT THESIS TITLE
15Y61S0410 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION
OF ALISKIREN AND AMLODIPINE
15Y61S0302 COMPARISON OF EFFECT OF NATURAL AND SYNTHETIC POLYMERS ON IN VITRO DRUG
RELEASE IN FORMULATION OF CONTROLLED RELEASED BY USING ATOMOXETINE HCL
15Y66S0302 FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF GASTRORETENTIVE
DRUG DELIVERY OF TRAMADOL HYDROCHLORIDE
15Y66S0301 FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF
RIZATRIPTAN BENZOATE
15Y61S0305 FORMULATION AND INVITRO EVALUATION OF LAMOTRIGINE
36
HTNO PROJECT THESIS TITLE
ORAL THIN FILMS
15Y61S1023 Product registration strategies, Patent filing to India, USA. Current Appraisal Procedure for
New drug regulation standards and guidelines issued by regulatory authorities by India, USA & EU
15Y61S1002 COMMERCIALASPECTSOFREGULATORYAPPROVALSAND REGULATIONSING8COUNTRIES
15Y66S0308 PREPARATION AND IN VITRO CHARACTERISATION URAPIDIL
FAST DISSOLVING TABLETS USING SOLID DISPERSION TECHNIQUE
15Y66S0310 FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF FLOATING
DRUG DELIVERY OF GLIBENCLAMIDE
15Y66S0316 FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE
MATRIX TABLETS OF MEBEVERINE BY USING NATURAL POLYMERS
15Y61S0301 FORMULATION AND EVALUATION OF NIZATIDINE FLOATING TABLETS
15Y61S0402 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF NEVIRAPINE
IN BULK AND TABLET FORMULATION
15Y61S0409 METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION
OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL
FORMULATION AND BIORELEVANT DISSOLUTION MEDIA BY CHROMATOGRAPHIC TEC
37
HTNO PROJECT THESIS TITLE
15Y66S0404 METHOD DEVELOPMENT AND VALIDATION OF IMATINIB MESYLATE BY RPHPLC
15Y66S0309 DESIGN AND EVALUATION OF NARATRIPTAN DISPERSABLE TABLETS
15Y66S0411 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS
ESTIMATION OF CETIRIZINE AND PSEUDOEPHEDRINE
16Y61S0403
A Novel Method for
Chromatographic Determination of
Ciprofloxacin and Metronidazole in
Pure Form and Formulation by
Using RP-HPLC
16Y61S1020
CHALLENGES OF DRUG
REGULATORY SUBMISSION IN
INDIA AND REGULATIONS ON
LABELLING AND
ADVERTISMENTS
16Y61S1011
Approval, Manufacture and
Marketing Regulations of Medical
Devices in Regulated Markets
USFDA, European Union, India
16Y61S1022
REGULATORY REQUIREMENTS
FOR SUBMISSION AND
COMPILATION OF DOSSIER
FOR PRESCRIPTION
MEDICINES (PARENTERALS) IN
AUSTRALIA-TGA
16Y61S1018
REGULATIONS - OF - NARCOTIC
- DRUGS
16Y61S0401
SIMPLE AND SENSITIVE
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION OF LAMIVUDINE
38
AND NEVIRAPINE BY RP-HPLC
16Y66S0415
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION FOR THE
ESTIMATION OF
DAPAGLIFLOZIN AND
METFORMIN BY RP-HPLC
16Y61S0410
RP HPLC METHOD
DEVELOPMENT AND
VALIDATION OF
BICAULTAMIDE AND
ATENOLOL IN ITS PURE
DOSAGE FORMS
16Y66S0406
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION FOR THE
SIMULTANEOUS ESTIMATION
OF ACYCLOVIR AND
VALACYCLOVIRBY RPHPLC
METHOD
16Y66S0410
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION OF GEMICTABINE
AND CLARITHROMYCIN IN
COMBINED DOSAGE FORM BY
RP-HPLC
16Y66S0419
A PROSPECTIVE VALIDATION
OF BISOPROLOL FUMERATE
AND HYDROCHLOROTHIAZIDE
IN ITS PURE AND BULK DOSAGE
FORMS BY USING RP HPLC
TECHNIQUE
16Y66S0409
METHOD DEVELOPMENT AND
VALIDATION OF
GILCOPYRROLATE AND
FORMOTEROL FUMERATE BY
_DB
16Y66S0417
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION FOR
SIMULTANEOUS ESTIMATION
OF AMLODIPINE AND
BENAZEPRIL IN
PHARMACEUTICAL DOSAGE
39
16Y61S1001
REGULATORY ISSUES OF
IMPORT OF PHARMACEUTICAL
PRODUCTS IN USA AND
CANADA
16Y61S1019
COMMERCIAL ASPECTS OF
REGULATORY APPROVALS
AND REGULATIONS UNDER
BRICS
16Y61S1004
HERBAL MEDICINE: A
GROWING FIELD WITH A LONG
TRADITION
16Y61S1003
LATEST TRENDS IN ARCHIVING
OF REGULATORY SUBMISSION
16Y61S1005
ADVERSE EVENT REPORTING
REQUIREMENTS IND AND POST
MARKETING
16Y61S1008
AN ANALYSIS OF FDA RECENT
DRUG GMP WARNING LETTERS
16Y61S0408
NOVEL HPLC METHOD FOR
SIMULTANEOUS ESTIATION OF
DOXYLAMINE AND
PYRIDOXINE IN BULK AND
COMBINEDDOSAGE FORM
16Y66S0418
A NEW METHOD
DEVELOPMENT BY RP HPLC
METHOD FOR
CANAGLAFLOZIN
16Y61S0407
A NEW METHOD
DEVELOPMENT AND
VALIDATION OF
SULFAMETHOXAZOLE AND
TRIMETHOPRIM IN ITS PURE
AND PHARMACEUTICAL
DOSAGE FORM
16Y61S1010
CURRENT TRENDS IN REVIEW
OF CTD DOSSIER
16Y61S0405
A NEW RP-HPLC METHOD
DEVELOPMENT AND
VALIDATION FOR
SIMULTANEOUS ESTIMATION
OF DICYCLOVERINE AND
40
TRAMADOL IN ITS PURE AND
PHARMACEUTICAL DOSAGE
FORMS”
16Y66S0408
A NEW VALIDATED RP-HPLC
METHOD FOR
DETERMINATION OF
CIPROFLOXACIN AND
ORNIDAZOLE IN BULK
PHARMACEUTICAL DOSAGE
FORMS
16Y61S0414
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION FOR THE
SIMULTANEOUS ESTIMATION
OF HYDROCHLORTHIAZIDE
AND RESERPINE BY USING RP-
HPLC TECHNIQUE
16Y66S0413
ANALYTICAL-METHOD-
DEVELOPMENT-AND-
VALIDATION-FOR-
IVERMECTIN-AND-
ALBENDAZOLE-IN-COMBINE-
DOSAGE-FORM- BY-RP-HPLC
16Y61S0409
ANAYTICAL METHOD
DEVELOPMENT AND
VALIDATION FOR THE
SIMULTANEOUS ESTIMATION
OF METFORMIN AND
ALOGLIPTIN BY RP-HPLC
METHOD
16Y61S0413
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION OF PIPERAQUINE
TETRAPHOSPHATE AND
DIHYDROARTEMISININ IN
COMBINE DOSAGE FORMS
16Y61S1016
INTER RELATIONSHIP
BETWEEN RA, QA, QC FOR
REGULATORY SUBMISSION
16Y61S1012
CURRENT REGULATION FOR
VARIATION FILINGS FOR THE
REGISTERED PRODUCTS
16Y66S0407 A NEW VALIDATED RP-HPLC
41
METHOD FOR
DETERMINATION OF
ROSUVASTAIN AND
TELMISARTAN IN BULK AND
PHARMACEUTICAL DOSAGE
FORM
16Y61S0406
A NEW METHOD
DEVELOPMENT AND
VALIDATION OF
AZITHROMCYCIN AND
CEFIXIME IN ITS PURE AND
PHARMACEUTICAL DOSAGE
FORM
16Y66S0412
A NOVEL RP-HPLC METHOD
FOR DEVELOPMENT AND
VALIDATION OF
SIMULTANEOUSLY
ASSESSMENT OF MECLIZINE
HYDROCHLORIDE AND
PYRIDOXINE
16Y66S0402
NOVEL RP-HPLC METHOD
DEVELOPMENT AND
VALIDATION FOR ESTIATION
OF CYTARABINE IN BULK AND
COMBINEDDOSAGE FORM
16Y66S0403
“.A NEW VALIDATED RP-HPLC
METHOD FOR ESTIMATION OF
AMBROXOL AND AMOXICILLIN
IN BULK AND
PHARMACEUTICAL DOSAGE
FORMS
16Y61S0416
SIMPLE AND SENSITIVE
ANALYTICAL METHOD
DEVELOPMENT AND
VALIDATION OF
NITAZOXANIDE AND
OFLOXACIN BY RP-HPLC
16Y61S0412
DEVELOPMENT AND
VALIDATION OF HIGH
PERFORMANCE LIQUID
CHROMATOGRAPHY METHOD
FOR THE DETERMINATION OF
DICYCLOMINE AND
CHLORIDAZEPOXIDE IN
PHARMACEUTICAL DOSAGE
42
FORM
16Y61S0301
FORMULATION AND
EVALUATION OF RAPID ON SET
MOUTH DISSOLVING FILM
16Y61S0317
FORMULATION DEVELOPMENT
AND INVITRO EVALUATION OF
ARIPIPRAZOLE
ORODISPERSIBLE TABLETS
16Y61S1009
CURRENT TRENDS IN
REGULATORY PROJECT
MANAGEMENT AND DRUG
APPROVALS IN USA
16Y61S1015
EV¿LU¿T¿¿N ¿F ¿MPL¿C¿T¿¿NS
¿F ¿MPLEMENT¿T¿¿N ¿F
QU¿L¿TY BY DES¿GN ¿N
PH¿RM¿CEUT¿C¿L
PR¿CESS¿NG.
16Y61S1017
Challenges in regulatory filings for
generic products
16Y61S1023
C¿MPARATIV¿ G¿N¿RIC DRUG
SUBMISSI¿N PR¿C¿DUR¿ F¿R US
& ¿UR¿P¿ MARK¿T
16Y61S1024
MARKETING AUTHORIZATION
OF NEW DRUGS IN EUROPE
AND USA
PhD
SUBJECTS HANDLED & HANDING
Adv.Instrumental Analysis Adv.
Medicinal Chemistry Adv. Natural Chemistry
Adv .Organic Chemistry Pharmacoinformatics
Patent & Intellectual Property Rights and Forensic Pharmacy
Environmental Chemistry
SKILLS & FIELDS OF SPECIAL INTEREST
Extraction of Phyto-Constituents
Isolation Techniques, Chromatographic Techniques
Interpretation of compounds, HPLC, LC-MS,NMR, IR
43
Tissue Culture, Handling of Animals
PERSONAL DETAILS
First name Suthakaran
Last name Raj
Sex Male
Date of Birth 04-06-1975
Nationality Indian
References
1) Dr. T.V. Narayana, Director & Principal
President, IPA
Vikas Institute of Pharmaceutical Sciences
Nidigatla Village, Korukonda Mandal, Near Airport
Rajahmundry, E.G. Dist, Andhra Pradesh - 533103
Ph. No. (0883) 2007843, Fax : 244102
+91 98450 20474,
E-mail : [email protected]
2) S.Kavimani M.Pharm.,PhD
Professor and HOD
Department of Pharmacology
College of Pharmacy
Mother therasa Post graduate Institute of Health Sciences
Puducherry-605006, India, Mobile: +919443085956
3) Dr.M.Bhagavan Raju M.Pharm.,PhD,
Professor and Principal
Department of Pharm. Chemistry
C.M College of Pharmacy
Malla Reddy group of institutions
Medchal, Hyderabad, Andhra Pradesh, India. Mobile:09348161227
DECLARATION
I hereby declare that the information furnished above are true and correct to the best of my
knowledge and belief.